Ningbo Menovo Pharmaceutical (603538.SH) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 9.4...
Zhixun Finance APP reports that Ningbo Menovo Pharmaceutical (603538.SH) released the third quarter report for 2024. The company's revenue for the first three quarters was 0.949 billion yuan, a year-on-year increase of 2.21%; net income attributable to shareholders of the listed company was 63.2504 million yuan, a year-on-year increase of 15.97%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 52.4464 million yuan, a year-on-year decrease of 1.15%; basic earnings per share were 0.29 yuan per share.